Cover Image
市場調查報告書

十二指腸癌症:全球臨床實驗檢討

Duodenal Cancer Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 297516
出版日期 內容資訊 英文 58 Pages
訂單完成後即時交付
價格
Back to Top
十二指腸癌症:全球臨床實驗檢討 Duodenal Cancer Global Clinical Trials Review, H1, 2014
出版日期: 2014年03月12日 內容資訊: 英文 58 Pages
簡介

本報告提供全球十二指腸癌症治療藥臨床實驗的相關調查,彙整各地區,Phase別,各狀態臨床實驗趨勢,主要企業和研究所等臨床實驗簡介,為您概述為以下內容。

目錄

簡介

  • 十二指腸癌症
  • 報告指南

臨床試驗:各地區

  • 臨床試驗:各國
    • 對臨床實驗有所貢獻的前幾名國家 - 亞太地區
    • 對臨床實驗有所貢獻的前五國 - 歐洲
    • 對臨床實驗有所貢獻的前幾名國家 - 北美

臨床試驗 G7各國

臨床試驗 G7各國,Phase別

臨床試驗 G7各國,各臨床實驗狀態

臨床試驗 E7各國

臨床試驗 Phase別

  • 進行中的臨床實驗:Phase別

臨床試驗:各臨床實驗狀態

未完成的臨床實驗

每段時期的實驗人數

有力的贊助商

  • 主要參與臨床實驗的企業

潛力治療藥物

  • 臨床試驗簡介
  • 臨床試驗概要:前幾名企業
    • Silence Therapeutics AG
    • Oncothyreon Inc.
    • F. Hoffmann-La Roche Ltd.
  • 臨床試驗概要:最高級大學 / 研究機關 / 醫院
    • National Cancer Institute
    • 和歌山縣立醫科大學
    • 名古屋大學
    • Seoul National University Hospital
    • 東京大學
    • Thomas Jefferson University
    • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
    • Odense University Hospital
    • Weill Cornell Medical College
    • USC Norris Comprehensive Cancer Center

5件主要臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二次調查
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

圖表

目錄
Product Code: GDHC2028CTIDB

GlobalData's clinical trial report, "Duodenal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Duodenal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Duodenal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Duodenal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Duodenal Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Duodenal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Duodenal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Duodenal Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Duodenal Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Silence Therapeutics AG
      • Clinical Trial Overview of Silence Therapeutics AG
      • Oncothyreon Inc.
      • Clinical Trial Overview of Oncothyreon Inc.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Wakayama Medical University
      • Clinical Trial Overview of Wakayama Medical University
      • Nagoya University
      • Clinical Trial Overview of Nagoya University
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • The University of Tokyo
      • Clinical Trial Overview of The University of Tokyo
      • Thomas Jefferson University
      • Clinical Trial Overview of Thomas Jefferson University
      • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
      • Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University
      • Odense University Hospital
      • Clinical Trial Overview of Odense University Hospital
      • Weill Cornell Medical College
      • Clinical Trial Overview of Weill Cornell Medical College
      • USC Norris Comprehensive Cancer Center
      • Clinical Trial Overview of USC Norris Comprehensive Cancer Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Duodenal Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Duodenal Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Duodenal Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Duodenal Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Duodenal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Silence Therapeutics AG, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncothyreon Inc., 2014*
  • Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wakayama Medical University, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya University, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by USC Norris Comprehensive Cancer Center, 2014*

List of Figures

  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Proportion of Duodenal Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Duodenal Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Duodenal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top